{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:27:59Z","timestamp":1792052879585,"version":"4.4.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,8]]},"DOI":"10.7759\/cureus.94134","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:52:13Z","timestamp":1759942333000},"source":"Crossref","is-referenced-by-count":5,"title":["Cardio-Renal Metabolic Syndrome: An Integrated Approach to Prevention and Management"],"prefix":"10.7759","author":[{"given":"Adeshpal","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemanth","family":"Kesani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidhant","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tareq Mohammed","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.12.026","article-title":"Dapagliflozin and all-cause hospitalizations in patients with heart failure with preserved ejection fraction","volume":"81","author":"Vaduganathan M","year":"2023","unstructured":"Vaduganathan M, Claggett BL, Jhund P, et al.. Dapagliflozin and all-cause hospitalizations in patients with heart failure with preserved ejection fraction. J Am Coll Cardiol. 2023, 81:1004-6. 10.1016\/j.jacc.2022.12.026","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17071169","article-title":"In the era of cardiovascular-kidney-metabolic syndrome in cardio-oncology: from pathogenesis to prevention and therapy","volume":"17","author":"Quagliariello V","year":"2025","unstructured":"Quagliariello V, Berretta M, Bisceglia I, et al.. In the era of cardiovascular-kidney-metabolic syndrome in cardio-oncology: from pathogenesis to prevention and therapy. Cancers (Basel). 2025, 17:1169. 10.3390\/cancers17071169","journal-title":"Cancers (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/diab.37.12.1595","article-title":"Role of insulin resistance in human disease","volume":"37","author":"Reaven GM","year":"1988","unstructured":"Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988, 37:1595-607. 10.2337\/diab.37.12.1595","journal-title":"Diabetes"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco C","year":"2008","unstructured":"Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008, 52:1527-39. 10.1016\/j.jacc.2008.07.051","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2024.101195","article-title":"Burden of cardiovascular disease among the Western Pacific region and its association with human resources for health, 1990-2021: a systematic analysis of the Global Burden of Disease Study 2021","volume":"51","author":"Wang H","year":"2024","unstructured":"Wang H, Yu X, Guo J, et al.. Burden of cardiovascular disease among the Western Pacific region and its association with human resources for health, 1990-2021: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Reg Health West Pac. 2024, 51:101195. 10.1016\/j.lanwpc.2024.101195","journal-title":"Lancet Reg Health West Pac"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth GA","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, et al.. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020, 76:2982-3021. 10.1016\/j.jacc.2020.11.010","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32977-0","article-title":"The global burden of chronic kidney disease","volume":"395","author":"Cockwell P","year":"2020","unstructured":"Cockwell P, Fisher LA. The global burden of chronic kidney disease. Lancet. 2020, 395:662-4. 10.1016\/S0140-6736(19)32977-0","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-018-0812-z","article-title":"The global epidemic of the metabolic syndrome","volume":"20","author":"Saklayen MG","year":"2018","unstructured":"Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018, 20:12. 10.1007\/s11906-018-0812-z","journal-title":"Curr Hypertens Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2024.100882","article-title":"Prevalence and associated factors of chronic kidney disease among Truk\u00e1 Indigenous adults in Cabrob\u00f3, Brazil: a population-based study","volume":"38","author":"Gomes OV","year":"2024","unstructured":"Gomes OV, Freire de Souza CD, Nicacio JM, et al.. Prevalence and associated factors of chronic kidney disease among Truk\u00e1 Indigenous adults in Cabrob\u00f3, Brazil: a population-based study. Lancet Reg Health Am. 2024, 38:100882. 10.1016\/j.lana.2024.100882","journal-title":"Lancet Reg Health Am"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017030253","article-title":"Particulate matter air pollution and the risk of incident CKD and progression to ESRD","volume":"29","author":"Bowe B","year":"2018","unstructured":"Bowe B, Xie Y, Li T, Yan Y, Xian H, Al-Aly Z. Particulate matter air pollution and the risk of incident CKD and progression to ESRD. J Am Soc Nephrol. 2018, 29:218-30. 10.1681\/ASN.2017030253","journal-title":"J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.305697","article-title":"Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms","volume":"116","author":"Hall JE","year":"2015","unstructured":"Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015, 116:991-1006. 10.1161\/CIRCRESAHA.116.305697","journal-title":"Circ Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2010.02.002","article-title":"Sympathetic nervous activation in obesity and the metabolic syndrome-causes, consequences and therapeutic implications","volume":"126","author":"Lambert GW","year":"2010","unstructured":"Lambert GW, Straznicky NE, Lambert EA, Dixon JB, Schlaich MP. Sympathetic nervous activation in obesity and the metabolic syndrome-causes, consequences and therapeutic implications. Pharmacol Ther. 2010, 126:159-72. 10.1016\/j.pharmthera.2010.02.002","journal-title":"Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/er.2007-0006","article-title":"Cardiovascular actions of insulin","volume":"28","author":"Muniyappa R","year":"2007","unstructured":"Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr Rev. 2007, 28:463-91. 10.1210\/er.2007-0006","journal-title":"Endocr Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-4005-4","article-title":"Oxidative stress in chronic kidney disease","volume":"34","author":"Daenen K","year":"2019","unstructured":"Daenen K, Andries A, Mekahli D, Van Schepdael A, Jouret F, Bammens B. Oxidative stress in chronic kidney disease. Pediatr Nephrol. 2019, 34:975-91. 10.1007\/s00467-018-4005-4","journal-title":"Pediatr Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita K","year":"2010","unstructured":"Matsushita K, van der Velde M, Astor BC, et al.. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010, 375:2073-81. 10.1016\/S0140-6736(10)60674-5","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60572-8","article-title":"Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study","volume":"380","author":"Tonelli M","year":"2012","unstructured":"Tonelli M, Muntner P, Lloyd A, et al.. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet. 2012, 380:807-14. 10.1016\/S0140-6736(12)60572-8","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-1-200601030-00006","article-title":"Body mass index and risk for end-stage renal disease","volume":"144","author":"Hsu CY","year":"2006","unstructured":"Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006, 144:21-8. 10.7326\/0003-4819-144-1-200601030-00006","journal-title":"Ann Intern Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","unstructured":"Global, regional, and national burden of chronic kidney disease, 1990-2017. a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020, 395:709-33. 10.1016\/S0140-6736(20)30045-3","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4501","article-title":"rends in the prevalence of metabolic syndrome in the United States, 2011-2016","volume":"323","author":"Hirode G","year":"2020","unstructured":"Hirode G, Wong RJ. rends in the prevalence of metabolic syndrome in the United States, 2011-2016. JAMA. 2020, 323:2526-8. 10.1001\/jama.2020.4501","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.10.2436","article-title":"Glycemic status and development of kidney disease: the Framingham Heart Study","volume":"28","author":"Fox CS","year":"2005","unstructured":"Fox CS, Larson MG, Leip EP, Meigs JB, Wilson PW, Levy D. Glycemic status and development of kidney disease: the Framingham Heart Study. Diabetes Care. 2005, 28:2436-40. 10.2337\/diacare.28.10.2436","journal-title":"Diabetes Care"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2011.02.391","article-title":"High-normal albuminuria and risk of heart failure in the community","volume":"58","author":"Blecker S","year":"2011","unstructured":"Blecker S, Matsushita K, K\u00f6ttgen A, Loehr LR, Bertoni AG, Boulware LE, Coresh J. High-normal albuminuria and risk of heart failure in the community. Am J Kidney Dis. 2011, 58:47-55. 10.1053\/j.ajkd.2011.02.391","journal-title":"Am J Kidney Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0407-x","article-title":"A catalog of genetic loci associated with kidney function from analyses of a million individuals","volume":"51","author":"Wuttke M","year":"2019","unstructured":"Wuttke M, Li Y, Li M, et al.. A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat Genet. 2019, 51:957-72. 10.1038\/s41588-019-0407-x","journal-title":"Nat Genet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent C","year":"2011","unstructured":"Baigent C, Landray MJ, Reith C, et al.. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011, 377:2181-92. 10.1016\/S0140-6736(11)60739-3","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014010108","article-title":"High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study","volume":"26","author":"Bansal N","year":"2015","unstructured":"Bansal N, Hyre Anderson A, Yang W, et al.. High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol. 2015, 26:946-56. 10.1681\/ASN.2014010108","journal-title":"J Am Soc Nephrol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.11.023","article-title":"Association of longitudinal high-sensitivity troponin T with mortality in patients with chronic kidney disease","volume":"79","author":"Chesnaye NC","year":"2022","unstructured":"Chesnaye NC, Al-Sodany E, Szummer K, et al.. Association of longitudinal high-sensitivity troponin T with mortality in patients with chronic kidney disease. J Am Coll Cardiol. 2022, 79:327-36. 10.1016\/j.jacc.2021.11.023","journal-title":"J Am Coll Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac528","article-title":"Albuminuria as a marker of systemic congestion in patients with heart failure","volume":"44","author":"Boorsma EM","year":"2023","unstructured":"Boorsma EM, Ter Maaten JM, Damman K, et al.. Albuminuria as a marker of systemic congestion in patients with heart failure. Eur Heart J. 2023, 44:368-80. 10.1093\/eurheartj\/ehac528","journal-title":"Eur Heart J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04010907","article-title":"Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study","volume":"3","author":"Bennett M","year":"2008","unstructured":"Bennett M, Dent CL, Ma Q, et al.. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol. 2008, 3:665-73. 10.2215\/CJN.04010907","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.113.000952","article-title":"Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis","volume":"7","author":"Kestenbaum B","year":"2014","unstructured":"Kestenbaum B, Sachs MC, Hoofnagle AN, et al.. Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis. Circ Heart Fail. 2014, 7:409-17. 10.1161\/CIRCHEARTFAILURE.113.000952","journal-title":"Circ Heart Fail"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.112.000129","article-title":"Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH","volume":"6","author":"van der Velde AR","year":"2013","unstructured":"van der Velde AR, Gullestad L, Ueland T, et al.. Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH. Circ Heart Fail. 2013, 6:219-26. 10.1161\/CIRCHEARTFAILURE.112.000129","journal-title":"Circ Heart Fail"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2011.11.011","article-title":"Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study","volume":"5","author":"Kalogeropoulos AP","year":"2012","unstructured":"Kalogeropoulos AP, Georgiopoulou VV, deFilippi CR, Gottdiener JS, Butler J. Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study. JACC Cardiovasc Imaging. 2012, 5:131-40. 10.1016\/j.jcmg.2011.11.011","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.122.014454","article-title":"Prognostic value of cardiac magnetic resonance imaging in patients with a working diagnosis of MINOCA \u2014 an outcome study with up to 10 years of follow-up","volume":"16","author":"Konst RE","year":"2023","unstructured":"Konst RE, Parker M, Bhatti L, et al.. Prognostic value of cardiac magnetic resonance imaging in patients with a working diagnosis of MINOCA \u2014 an outcome study with up to 10 years of follow-up. Circ Cardiovasc Imaging. 2023, 16:e014454. 10.1161\/CIRCIMAGING.122.014454","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010492","article-title":"Diet, lifestyle, and the risk of type 2 diabetes mellitus in women","volume":"345","author":"Hu FB","year":"2001","unstructured":"Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001, 345:790-7. 10.1056\/NEJMoa010492","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158959","article-title":"Low-grade inflammation, oxidative stress and risk of invasive post-menopausal breast cancer - a nested case-control study from the Malm\u00f6 Diet and Cancer cohort","volume":"11","author":"Dias JA","year":"2016","unstructured":"Dias JA, Fredrikson GN, Ericson U, et al.. Low-grade inflammation, oxidative stress and risk of invasive post-menopausal breast cancer - a nested case-control study from the Malm\u00f6 Diet and Cancer cohort. PLoS One. 2016, 11:e0158959. 10.1371\/journal.pone.0158959","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw452","article-title":"Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies","volume":"32","author":"Xia J","year":"2017","unstructured":"Xia J, Wang L, Ma Z, et al.. Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Nephrol Dial Transplant. 2017, 32:475-87. 10.1093\/ndt\/gfw452","journal-title":"Nephrol Dial Transplant"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet","volume":"368","author":"Estruch R","year":"2013","unstructured":"Estruch R, Ros E, Salas-Salvad\u00f3 J, et al.. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013, 368:1279-90. 10.1056\/NEJMoa1200303","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199704173361601","article-title":"A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group","volume":"336","author":"Appel LJ","year":"1997","unstructured":"Appel LJ, Moore TJ, Obarzanek E, et al.. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997, 336:1117-24. 10.1056\/NEJM199704173361601","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.7.713","article-title":"Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women","volume":"168","author":"Fung TT","year":"2008","unstructured":"Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med. 2008, 168:713-20. 10.1001\/archinte.168.7.713","journal-title":"Arch Intern Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler WC","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002, 346:393-403. 10.1056\/NEJMoa012512","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Wing RR","year":"2013","unstructured":"Wing RR, Bolin P, Brancati FL, et al.. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013, 369:145-54. 10.1056\/NEJMoa1212914","journal-title":"N Engl J Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.04.019","article-title":"The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries","volume":"158","author":"Teo K","year":"2009","unstructured":"Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J. 2009, 158:1-7.e1. 10.1016\/j.ahj.2009.04.019","journal-title":"Am Heart J"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.15.1909","article-title":"Improving primary care for patients with chronic illness: the chronic care model, part 2","volume":"288","author":"Bodenheimer T","year":"2002","unstructured":"Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, part 2. JAMA. 2002, 288:1909-14. 10.1001\/jama.288.15.1909","journal-title":"JAMA"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf S","year":"2000","unstructured":"Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000, 342:145-53. 10.1056\/NEJM200001203420301","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner BM","year":"2001","unstructured":"Brenner BM, Cooper ME, de Zeeuw D, et al.. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001, 345:861-9. 10.1056\/NEJMoa011161","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman B","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, et al.. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015, 373:2117-28. 10.1056\/NEJMoa1504720","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink HJ","year":"2020","unstructured":"Heerspink HJ, Stef\u00e1nsson BV, Correa-Rotter R, et al.. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020, 383:1436-46. 10.1056\/NEJMoa2024816","journal-title":"N Engl J Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso SP","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, et al.. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016, 375:311-22. 10.1056\/NEJMoa1603827","journal-title":"N Engl J Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso SP","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, et al.. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016, 375:1834-44. 10.1056\/NEJMoa1607141","journal-title":"N Engl J Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris GL","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD, et al.. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med. 2020, 383:2219-29. 10.1056\/NEJMoa2025845","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066603","article-title":"Long-term mortality after gastric bypass surgery","volume":"357","author":"Adams TD","year":"2007","unstructured":"Adams TD, Gress RE, Smith SC, et al.. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007, 357:753-61. 10.1056\/NEJMoa066603","journal-title":"N Engl J Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2017.01.010","article-title":"Bariatric surgery and kidney-related outcomes","volume":"2","author":"Chang AR","year":"2017","unstructured":"Chang AR, Grams ME, Navaneethan SD. Bariatric surgery and kidney-related outcomes. Kidney Int Rep. 2017, 2:261-70. 10.1016\/j.ekir.2017.01.010","journal-title":"Kidney Int Rep"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.09.031","article-title":"Kidney outcomes three years after bariatric surgery in severely obese adolescents","volume":"91","author":"Nehus EJ","year":"2017","unstructured":"Nehus EJ, Khoury JC, Inge TH, Xiao N, Jenkins TM, Moxey-Mims MM, Mitsnefes MM. Kidney outcomes three years after bariatric surgery in severely obese adolescents. Kidney Int. 2017, 91:451-8. 10.1016\/j.kint.2016.09.031","journal-title":"Kidney Int"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2020.0829","article-title":"Bariatric surgery and long-term survival in patients with obesity and end-stage kidney disease","volume":"155","author":"Sheetz KH","year":"2020","unstructured":"Sheetz KH, Gerhardinger L, Dimick JB, Waits SA. Bariatric surgery and long-term survival in patients with obesity and end-stage kidney disease. JAMA Surg. 2020, 155:581-8. 10.1001\/jamasurg.2020.0829","journal-title":"JAMA Surg"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.01.002","article-title":"US Renal Data System 2020 annual data report: epidemiology of kidney disease in the United States","volume":"77","author":"Johansen KL","year":"2021","unstructured":"Johansen KL, Chertow GM, Foley RN, et al.. US Renal Data System 2020 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2021, 77:A7-8. 10.1053\/j.ajkd.2021.01.002","journal-title":"Am J Kidney Dis"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac144","article-title":"De novo major cardiovascular events in kidney transplant recipients: a comparative matched cohort study","volume":"38","author":"Kim JE","year":"2023","unstructured":"Kim JE, Park J, Park S, et al.. De novo major cardiovascular events in kidney transplant recipients: a comparative matched cohort study. Nephrol Dial Transplant. 2023, 38:499-506. 10.1093\/ndt\/gfac144","journal-title":"Nephrol Dial Transplant"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1111\/nep.14020","article-title":"Epidemiology of cardiovascular death in kidney failure: an Australian and New Zealand cohort study using data linkage","volume":"27","author":"Khou V","year":"2022","unstructured":"Khou V, De La Mata NL, Kelly PJ, Masson P, O'Lone E, Morton RL, Webster AC. Epidemiology of cardiovascular death in kidney failure: an Australian and New Zealand cohort study using data linkage. Nephrology (Carlton). 2022, 27:430-40. 10.1111\/nep.14020","journal-title":"Nephrology (Carlton)"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-024-03934-y","article-title":"Real-world effectiveness of hemodialysis modalities: a retrospective cohort study","volume":"26","author":"Zhang Y","year":"2025","unstructured":"Zhang Y, Winter A, Ferreras BA, et al.. Real-world effectiveness of hemodialysis modalities: a retrospective cohort study. BMC Nephrol. 2025, 26:9. 10.1186\/s12882-024-03934-y","journal-title":"BMC Nephrol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.124.071689","article-title":"Cardiovascular, kidney, and safety outcomes with GLP-1 receptor agonists alone and in combination with SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis","volume":"150","author":"Neuen BL","year":"2024","unstructured":"Neuen BL, Fletcher RA, Heath L, et al.. Cardiovascular, kidney, and safety outcomes with GLP-1 receptor agonists alone and in combination with SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis. Circulation. 2024, 150:1781-90. 10.1161\/CIRCULATIONAHA.124.071689","journal-title":"Circulation"},{"key":"ref58","doi-asserted-by":"crossref","DOI":"10.1038\/s44324-025-00068-z","article-title":"SGLT2 inhibitors across various patient populations in the era of precision medicine: the multidisciplinary team approach","volume":"3","author":"McLean P","year":"2025","unstructured":"McLean P, Bennett J, Woods E, et al.. SGLT2 inhibitors across various patient populations in the era of precision medicine: the multidisciplinary team approach. npj Metab Health Dis. 2025, 3:29-37.","journal-title":"npj Metab Health Dis"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay M","year":"2015","unstructured":"Nikpay M, Goel A, Won HH, et al.. A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet. 2015, 47:1121-30. 10.1038\/ng.3396","journal-title":"Nat Genet"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20156297","article-title":"Revisiting biomarker discovery by plasma\u00a0proteomics","volume":"13","author":"Geyer PE","year":"2017","unstructured":"Geyer PE, Holdt LM, Teupser D, Mann M. Revisiting biomarker discovery by plasma\u00a0proteomics. Mol Syst Biol. 2017, 13:942. 10.15252\/msb.20156297","journal-title":"Mol Syst Biol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14828","article-title":"Artificial intelligence-assisted automated heart failure detection and classification from electronic health records","volume":"11","author":"Oo MM","year":"2024","unstructured":"Oo MM, Gao C, Cole C, et al.. Artificial intelligence-assisted automated heart failure detection and classification from electronic health records. ESC Heart Fail. 2024, 11:2769-77. 10.1002\/ehf2.14828","journal-title":"ESC Heart Fail"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure","volume":"305","author":"Tangri N","year":"2011","unstructured":"Tangri N, Stevens LA, Griffith J, et al.. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011, 305:1553-9. 10.1001\/jama.2011.451","journal-title":"JAMA"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2015.01.044","article-title":"ST2 testing for chronic heart failure therapy monitoring: the International ST2 Consensus Panel","volume":"115","author":"Januzzi JL","year":"2015","unstructured":"Januzzi JL, Pascual-Figal D, Daniels LB. ST2 testing for chronic heart failure therapy monitoring: the International ST2 Consensus Panel. Am J Cardiol. 2015, 115:70B-5B. 10.1016\/j.amjcard.2015.01.044","journal-title":"Am J Cardiol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01170212","article-title":"Circulating and urinary microRNAs in kidney disease","volume":"7","author":"Lorenzen JM","year":"2012","unstructured":"Lorenzen JM, Thum T. Circulating and urinary microRNAs in kidney disease. Clin J Am Soc Nephrol. 2012, 7:1528-33. 10.2215\/CJN.01170212","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker PM","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, et al.. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017, 377:1119-31. 10.1056\/NEJMoa1707914","journal-title":"N Engl J Med"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.3390\/biom14010137","article-title":"Kidney fibrosis and oxidative stress: from molecular pathways to new pharmacological opportunities","volume":"14","author":"Patera F","year":"2024","unstructured":"Patera F, Gatticchi L, Cellini B, Chiasserini D, Reboldi G. Kidney fibrosis and oxidative stress: from molecular pathways to new pharmacological opportunities. Biomolecules. 2024, 14:137. 10.3390\/biom14010137","journal-title":"Biomolecules"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/418058-cardio-renal-metabolic-syndrome-an-integrated-approach-to-prevention-and-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:52:22Z","timestamp":1759942342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/418058-cardio-renal-metabolic-syndrome-an-integrated-approach-to-prevention-and-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":66,"URL":"https:\/\/doi.org\/10.7759\/cureus.94134","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,8]]}}}